HighTower Advisors LLC Boosts Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

HighTower Advisors LLC increased its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 41.3% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 24,480 shares of the medical instruments supplier’s stock after acquiring an additional 7,152 shares during the period. HighTower Advisors LLC’s holdings in DENTSPLY SIRONA were worth $465,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Riverview Trust Co bought a new position in shares of DENTSPLY SIRONA during the 4th quarter valued at about $26,000. MassMutual Private Wealth & Trust FSB grew its position in DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,232 shares during the last quarter. UMB Bank n.a. raised its stake in shares of DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 564 shares in the last quarter. Quarry LP lifted its holdings in shares of DENTSPLY SIRONA by 455.0% in the 3rd quarter. Quarry LP now owns 3,036 shares of the medical instruments supplier’s stock worth $82,000 after acquiring an additional 2,489 shares during the last quarter. Finally, SRS Capital Advisors Inc. boosted its stake in shares of DENTSPLY SIRONA by 4,699.0% in the 4th quarter. SRS Capital Advisors Inc. now owns 4,607 shares of the medical instruments supplier’s stock valued at $87,000 after purchasing an additional 4,511 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the acquisition, the director now directly owns 81,971 shares of the company’s stock, valued at $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.52% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of brokerages have recently issued reports on XRAY. Wells Fargo & Company reduced their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating on the stock in a report on Friday, February 28th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Morgan Stanley dropped their price objective on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a report on Tuesday, December 17th. Finally, Mizuho reduced their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating on the stock in a research note on Thursday, March 13th. Twelve investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus target price of $23.33.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $14.93 on Monday. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company’s fifty day moving average price is $17.62 and its 200-day moving average price is $20.16. The stock has a market cap of $2.97 billion, a PE ratio of -7.21, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 12 month low of $14.78 and a 12 month high of $33.22.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a $0.16 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.29%. DENTSPLY SIRONA’s dividend payout ratio is currently -14.07%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.